Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01230684 · ClinicalTrials.gov registry record · NA
Contrast Enhanced Ultrasound vs. Computed Tomographic Angiography in the Detection of Endoleaks Following AAA Repair
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01230684: Clinical Trial NA study, sponsored by University of Michigan.
NCT01230684 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01230684, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of the study is to compare two different types of imaging techniques to identify endoleaks. Following the endovascular procedure, subjects are seen at one month to have computed tomographic angiography (CTA) to confirm the graft is not leaking (endoleak). CTA is the standard imaging technique used to identify endoleaks. This study will investigate if the image technique color duplex ultrasound with contrast enhanced ultrasound (CEUS) is a good tool to identify endoleaks too.
Interventions
- PROCEDURE Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-11 |
| Phase | NA |
Why NCT01230684 stopped before completion
NCT01230684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM) is the first listed.
NCT01230684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01230684 about?
NCT01230684 is a clinical study titled "Contrast Enhanced Ultrasound vs. Computed Tomographic Angiography in the Detection of Endoleaks Following AAA Repair". The purpose of the study is to compare two different types of imaging techniques to identify endoleaks. Following the endovascular procedure, subjects are seen at one month to have computed tomographic angiography (CTA) to confirm the graft is not leaking (endoleak). CTA is the standard imaging tech...
What is the current status of trial NCT01230684?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2010-12. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01230684?
The interventions under investigation include: Contrast Enhanced Ultrasound (Contrast Agent: OptisonTM) (PROCEDURE).
Who is sponsoring clinical trial NCT01230684?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01230684's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia